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Hypothalamic orexin/hypocretin neurons send long axonal projections through the dorsal
spinal cord in lamina I–II of the dorsal horn (DH) at the interface with the peripheral
nervous system (PNS). We show that in the DH OXA fibers colocalize with substance
P (SP) positive afferents of dorsal root ganglia (DRG) neurons known to mediate sensory
processing. Further, OR1 is expressed in p75NTR and SP positive DRG neurons, suggesting
a potential signaling pathway between orexin and DRG neurons. Interestingly, DRG
sensory neurons have a distinctive bifurcating axon where one branch innervates the
periphery and the other one the spinal cord (pseudo-unipolar neurons), allowing for
potential functional coupling of distinct targets. We observe that OR1 is transported
selectively from DRG toward the spinal cord, while OXA is accumulated retrogradely
toward the DRG. We hence report a rare situation of asymmetrical neuropeptide receptor
distribution between axons projected by a single neuron. These molecular and cellular data
are consistent with the role of OXA/OR1 in sensory processing, including DRG neuronal
modulation, and support the potential existence of an OX/HCRT circuit between CNS
and PNS.
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INTRODUCTION
Orexin A and B (OXA and B also known as hypocretin 1 and
2, HCRT1 and 2) are neuropeptides produced within the lat-
eral/perifornical hypothalamus, derived from a single prepro-
peptide (de Lecea et al., 1998; Sakurai et al., 1998). While their
cell bodies form a compact cluster within the hypothalamus,
OX/HCRT neurons project widely throughout the central ner-
vous system (CNS) from the olfactory bulbs to the spinal cord
in both mammals and fishes (Cutler et al., 1999; van den Pol,
1999; Appelbaum et al., 2009; de Lecea, 2010). These widespread
projections arematched by the expression of the two orexin recep-
tors (OR1 and 2) (Hervieu et al., 2001; Marcus et al., 2001).
OR1 displays higher affinity for OXA than OXB, whereas OR2
has equal affinity for both ligands. Orexins play a crucial role
in orchestrating mechanisms related to the level of arousal such
as feeding, reward-seeking, metabolism, and energy expenditure
(for review see Tsujino and Sakurai, 2013). This neuropeptidergic
system is particularly well known for stabilizing the sleep-wake
states and is responsible for narcolepsy when disrupted (Peyron
et al., 2000; Sakurai, 2013; Sorensen et al., 2013). As such, OX
innervations of other sleep-regulating brain nuclei are extensively
studied. While it is well known that OX axons project through-
out the dorsal spinal cord (Cutler et al., 1999; van den Pol, 1999;
Appelbaum et al., 2009; de Lecea, 2010), the interaction of the
central OX system with the peripheral nervous system (PNS)
including the dorsal root ganglia (DRG) (Hervieu et al., 2001) has
been less explored. Interestingly, several studies have shown that
OXA and OR1 can modulate sensory and nociception processing
(for review Chiou et al., 2010).
DRG neurons are pseudo-unipolar neurons that have the
unique property of projecting axon branches toward the spinal
cord and toward peripheral targets (Figure 1A) (Kandel et al.,
2000). In the periphery, DRG neurons innervate the skin and
muscle (Kandel et al., 2000). In the spinal cord, afferents of pro-
prioceptive DRG neurons terminate in the ventral horn, afferents
of cutaneous mechanoreceptive DRG neurons terminate in the
deep dorsal horn (DH) and afferents of nociceptive and ther-
moreceptive DRG neurons terminate in the superficial (lamina
I/II) DH (Kandel et al., 2000). The difference between projec-
tion areas of DRG neurons in the central and the PNS prompted
us to question whether neurotransmission material present in
both axon branches was identical (Delcroix et al., 2004). Here,
we show that in the DH of the spinal cord lamina I and II, DRG
afferents closely appose with the OXA descending innervation
arising from the hypothalamus. We also observed that OR1 is
expressed in DRG neuron cell bodies and detected in the dor-
sal root (DR) connecting the DRG to the spinal cord but not
in the sciatic nerve (SN). This data suggests that the antero-
grade axonal transport of OR1 can be directed toward one axon
branch and not the other. Consistent with this finding, OXA is
also detected in the DRG neuron cell bodies suggesting a retro-
grade transport from the spinal cord to the DRG. This body of
www.frontiersin.org February 2014 | Volume 8 | Article 20 | 1
Colas et al. Orexin and DRG neuron interaction
FIGURE 1 | OXA hypothalamic fibers appose with SP positive DRG
fibers in the dorsal horn. (A) Scheme of a spinal cord cross section
(modified from OpenStax College PNS course). Dorsal horn, site of
analyses presented below, is indicated in red. (B) Left panel: transversal
section of spinal cord stained for SP. SP decorates lamina I and II of the
dorsal horn. Right panel: longitudinal section of spinal cord stained for OXA.
OXA is present in lamina I and II of the dorsal horn. (C) Transversal section
of lamina I and II of the dorsal horn stained for OXA (red) and SP (green).
(D) While some colocalization was visible in B, juxtaposition became clear
only after a 3D reconstruction (SP in yellow and OXA in red). In inserts 1, 2,
and 3, SP terminals in the section were colocalized or in contact with OXA
terminals. Inserts were rotated by 180◦ (first panel under the insert) and by
270◦ (second panel under the insert). White circles show apposition of SP
and OXA and a red circle shows an example of false positive.
work supports at the cellular level the existence of an interaction
between the central hypothalamic orexin neurons and the PNS.
Understanding the influence of orexins on the PNS physiology is
not only important for its function in arousal threshold changes
but also potentially relevant to OXA anti-nociceptive function
(Dauvilliers et al., 2011; Doghramji, 2012; Roehrs et al., 2012).
RESULTS
OREXIN A AXONAL FIBERS AND SP POSITIVE FIBERS FROM DRG ARE
JUXTAPOSED IN SPINAL CORD LAMINA I AND II
CNS OX/HCRT neurons are well known for their long axonal
projections to the dorsal spinal cord (Cutler et al., 1999; van den
Pol, 1999; Appelbaum et al., 2009). Similarly, PNS axons com-
ing from the DRG and releasing Substance P (SP) connect the
CNS in lamina I and II of the spinal cord DH (Nichols et al.,
1999), suggesting a possible interaction with the OX/HCRT cir-
cuit in these layers. Thus, we first inquired if afferents of SP
neurons in the spinal cord were in physical contact with OXA-
positive fibers arising from the hypothalamus. Axons expressing
OXA propagate into lamina I and II by spreading longitudinally
(Figure 1B) (Cutler et al., 1999; van den Pol, 1999) whereas the
SP positive fibers branch and spread robustly in a coronal fashion
in these layers (Figure 1B). OXA and SP double immunofluo-
rescent histochemistry staining suggested colocalization of these
fibers (Figure 1C), but due to these innervation orthogonal char-
acteristics it was difficult to analyze the extent of the apposition
between SP and OXA either in coronal sections or in longitudinal
sections. 3D reconstructions of coronal sections (see Figure 1D)
clearly showed that OXA and SP terminals are juxtaposed in lam-
ina I and II (Figure 1D). We found that 22 ± 4% (from 4 rats, 2
sections taken from the DH) of OXA terminals colocalized with
SP terminals, whereas 75± 6% (from 4 rats, 2 sections taken from
the DH) of SP terminals colocalized with OXA terminals.
OREXIN RECEPTOR 1 IS EXPRESSED IN DORSAL ROOT GANGLIA
p75NTR/SP NEURONS
Since the OXA positive terminals were potentially in contact with
SP positive fibers, we tested if OR1 was present in DRG neurons
(see schematic Figure 2A) expressing SP or p75 neurotrophin
receptor (p75NTR), another marker for sensory neurons (Delcroix
et al., 1998, 2003) (Figure 2B). Staining for p75NTR and OR1 was
neuronal since the nuclei of satellite cells stained with DAPI did
not show OR1 staining (Figure 2B). The percentage of p75NTR-
positive cells was 43 ± 4% (from 4 rats, 2 sections taken from
the middle of the DRG). The percentage of OR1-positive cells
was 57 ± 5% (from 4 rats, 2 sections taken from the middle of
the DRG). The neuroanatomical analysis showed that p75NTR-
positive neurons were predominantly small and medium sized
neurons (cell bodies ranging from 250 to 750μm2, Figure 2E).
The size of OR1-positive neurons was also small and medium
(Figures 2E,F). This size and morphology distribution was con-
sistent with our previous characterization of the DRG p75NTR and
trkA-expressing sensory neurons (Delcroix et al., 1998, 2003).
Importantly, double staining of DRGs shows that most, if not
all, of the p75NTR-positive neurons express OR1 (Figure 2B),
even if it was also clear that neurons other than p75NTR -positive
neurons were OR1 positive. DRG sections were also immuno-
stained for OR1 and SP (Figure 2C) and we observed that all
SP positive cells also expressed OR1 (Figure 2C). The large co-
expression of OR1 with p75NTR and SP markers hence further
supports a potential interaction between the OXA terminals and
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FIGURE 2 | OR1 is present in DRG neurons. (A) Scheme. DRG, site of
analyses presented below, is indicated in red. (B) DRG neurons stained for
p75NTR (red) and OR1 (green), nuclei were stained in blue with DAPI. Most
p75NTR neurons were OR1 positive (arrows). (C) DRG neurons stained for
SP (red) and OR1 (green). All SP positive neurons were strongly positive for
OR1. (D) SP (red) and OR1 (green) showed a punctuated pattern as well as
a clear colocalization in a third of SP puncta. (E) Size distribution of OR1 in
DRGs compared to the size distribution of all DRG neurons. (F) Percentage
of DRG neurons of a given size positive for OR1 (the numbers are given as
percentage above and below 50%; baseline 0 corresponds to 50% of
neurons positive for OR1). Arrows and white circles denote colocalization.
the DRG neurons. Higher magnification analysis of SP and OR1
double staining showed a robust punctate pattern in neuron cell
bodies (Figure 2D). 32 ± 6% (n = 10 neurons in 4 different
animals) of OR1 positive puncta in those cells colocalized with
SP. Because of the secreted nature of the SP neuropeptide, the
cytoplasmic colocalization of OR1 with SP prompted us to inves-
tigate whether OR1 expressed in DRG neurons was present in the
trafficking pathway that sends material toward nerve terminals.
OR1 IS ANTEROGRADELY ACCUMULATED FROM DRG TO THE SPINAL
CORD WHILE OXA IS RETROGRADELY ACCUMULATED FROM THE
SPINAL CORD TO THE DRG
Since the OXA positive terminals colocalize with SP positive fibers
in the spinal cord and OR1 is expressed in DRG neurons, we then
tested whether OR1 was anterogradely accumulated/transported
from the DRG to the spinal cord (see principle in Figure 3A).
We used the nerve crush method and axonal transport analysis
described in our previous works on nerve growth factor effects
on sensory neurons (Delcroix et al., 1998, 2003). We performed
laminectomies (bone removal allowing access to DRG and DR)
on rats and crushed the dorsal roots (DRs) arising from lum-
bar 4 and 5 (L4 and L5) DRGs (Figure 3A). Nerve crush leads to
accumulation of normally transported material on both sides of
the crush (Figure 3A). The DRs were collected at 3 time points,
0, 3, and 6 h (3 animals were used for each time point), and the
proximal section of the crushed DR was run on an SDS-Page gel
(Figure 3B, right panel). OR1 accumulated over time (Figure 3B,
right panel). As a control, DRG was also tested and as expected,
OR1 was expressed in the ganglia. In striking contrast, OR1 was
not accumulated in the SN toward the periphery even after 12 h
(Figure 3B, right panel). We do not know whether it involves
a passive or active transport, however this data clearly suggests
that OR1 is selectively accumulated toward the spinal cord and
not the periphery. This data further strengthens the possibility
of an orexin/hypocretin neurotransmission between the CNS and
PNS/DRG. More importantly, from a more general neurobiologi-
cal perspective, this observation is also a rare case of asymmetrical
neuropeptide receptor distribution between axons projected by a
single neuronal cell type.
We next tested whether OXA secreted by hypothalamus-
originating fiber terminals could be taken up by afferents arising
from the DRG. We looked for retrogradely transported OXA by
withdrawing material accumulated at the crush site of DRs aris-
ing from L4 and L5 DRGs (retrograde accumulation was harvested
after 6 h) (Figure 3B, left panel). OXA accumulated at the crush
site (n = 3 animals) as opposed to intact DRs (0 h transport)
(Figure 3B, left panel). Furthermore, we found that retrograde
transport of OXA was specific, as it was present in DRG neu-
ron cell bodies always colocalizing with its receptor (Figure 3C).
Altogether these results suggest the existence of neurotransmis-
sion between the central OX/HCRT neurons and the periph-
eral SP neurons. The existence of a functional circuit between
OX/HCRT and DRG neurons is yet to be fully demonstrated.
DISCUSSION
The discovery of molecular motors, and in particular kinesin,
has led to the realization that cell trafficking was a highly con-
trolled phenomenon (Vale et al., 1985). Despite our present
extended knowledge of cellular trafficking, our comprehension of
transport events in neurons is incomplete. Moreover, the possi-
bility of transport directed toward specific axon branches poses a
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FIGURE 3 | OR1 and OXA are transported in dorsal root axons.
(A) Scheme illustrating the crush and ligature experiments and
indicating the sites where tissue samples were collected to measure
OXA and OR1 accumulation. (B) Transport analysis (based on our
previous work Delcroix et al., 2003). Left panel, OXA is accumulated
after 6 h in the dorsal root suggesting a retrograde transport. Right
panel, 6 and 3 h OR1 accumulation proximal at a crush site in the
dorsal roots. The 0 h lane has been loaded with an intact root from the
same animal. Blot analysis and accumulation of OR1 was determined
using ImageJ and normalized to the 0 h value (see bar chart). Note the
progressive accumulation over time of OR1 suggesting an anterograde
transport. 12 h accumulation in the SN did not show OR1 accumulation.
DRG tissue was used as positive control. Lower panels, β-actin was
used as an internal loading control. (C) OXA (red) was present in the
DRG and always colocalized with OR1 (green) whereas OR1 could be
found without OXA (see white circle).
clear challenge to our understanding of axonal transport toward
specific targets. In this work we show that indeed a specific
protein, OR1, can be transported—via a mechanism yet to be
deciphered—in one axon branch (DR) but not in the other (SN).
Much evidence points to the existence of changes in transport
flux in axon branches. Goldberg and Schacher showed that cul-
tured Aplysia californica cerebral neurons grow from both ends of
both branches (Goldberg and Schacher, 1987). When a branch
was next to a target cell, bidirectional fast axonal transport of
organelles was more robust in that branch. A similar observa-
tion wasmade in hippocampal neurons by Ruthel andHollenbeck
(2003). Indirect evidence also pointed to differential axonal trans-
port in vivo. Schreyer and Skene showed that injuries of the SN or
the DR did have different effects in DRG neurons, implying the
existence of a different retrograde signal that might be linked to
a different composition in the proteins anterogradely transported
in both axon branches (Schreyer and Skene, 1993). Differential
transport in axon branches might also be linked to morphological
changes occurring in network rearrangements during embry-
onic and adult life (for review see Luo and O’Leary, 2005). It is
unclear what mechanism mediates differential transport in axon
branches and it is beyond the scope of this study. Nevertheless, in
this work we link differential OR1 accumulation to an OXA/SP
network that only exists in the spinal cord and not in the
periphery.
OXA was retrogradely accumulated from the spinal cord to
the DRG and was always detected in the DRG in the presence
of its receptor. The potential retrograde transport of a receptor-
bound neuropeptide may be an important process, which conveys
information from the synapse to the DRG cell bodies. OXA could
also play a role in the regulation of cell mechanisms as shown
for neuropeptide Y that regulates axonal transport of organelles
in neurites of cultured DRGs (Hiruma et al., 2002). In addi-
tion, OR1 is a G protein-coupled receptor (GPCR). Its binding
to OXA and potential subsequent internalization in SP-positive
synapses might have a similar role to the one played by the
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internalization of other DRG GPCRs. For instance, the opioid
receptor-like receptor controls the availability of calcium channels
through internalization and consequently modulates long-term
pain related signaling (Altier et al., 2006).
We do not demonstrate here the existence of a functional cir-
cuit between central OX/HCRT neurons and peripheral DRG
neurons, however we bring evidence suggesting a potential inter-
action between these neurons. While we do not show synaptic
connections, the paracrine release of OX/HCRT neuropeptides
in close proximity to DRG neuron fibers expressing OR1 could
suffice for neurotransmission. This hypothesis is substantiated by
the axon-specific accumulation of OR1 in DRG pseudo-unipolar
neurons and the presence of its ligand OXA in the cell bodies. We
believe that the presence of OXA neuropeptide in the DRG neu-
rons is due to its uptake and not to its cell-autonomous expression
in these neurons. Besides the lateral hypothalamus, OX/HCRT
mRNA has indeed never been detected in the nervous system
elsewhere in all species studied so far, including fishes (zebrafish
Faraco et al., 2006; Appelbaum et al., 2009, goldfish Nakamachi
et al., 2006), birds (chicken Ohkubo et al., 2002, quail Phillips-
Singh et al., 2003), and mammals (de Lecea et al., 1998; Sakurai
et al., 1998 and Luis de Lecea pers. commun.). Of course, we can-
not rule out a sub-threshold expression of OX/HCRT transcript
in the DRG, but it seems less likely compared to its uptake in the
dorsal spinal cord.
Finally, a potential network between the CNS and PNS may
account for the involvement of the OX/HCRT in the modula-
tion of sensorial processing. An increasing body of knowledge
shows that the orexin system is involved in pain regulation and
orexin peptides exert antinociceptive actions (Bingham et al.,
2001; Holland et al., 2005, 2006; Kajiyama et al., 2005; Mobarakeh
et al., 2005; Yan et al., 2008; Ho et al., 2011; Feng et al., 2012)
and for review Chiou et al. (2010). In particular, OXA decreases
nociception mostly via OR1 both at spinal and supra-spinal lev-
els in various models of pain. For instance, in an acute model of
pain (hot plate test), intrathecal injections of OXA proved to be
anti-nociceptive (Yamamoto et al., 2002). In addition, in a model
of chronic neuropathic pain (chronic constrictive injury of SN),
Jeong and Holden showed that stimulation of posterior hypotha-
lamus induces anti-nociception and that the anti-nociceptive
effect is mediated in part by the OR-1 receptor in the spinal cord
DH. Their findings, in combination with our findings suggest a
possible role of axonal transport of OR-1 andOXA in painmodels
of chronic constrictive nerve injuries (Jeong and Holden, 2009).
Cellular effects of orexins on pain mechanisms have scarcely been
studied so far, but it has been shown that orexins modulate the
electrophysiological properties of key pain modulatory centers,
such as the spinal cord DH and the ventro-lateral peri-aqueductal
gray vlPAG (Grudt et al., 2002; Ho et al., 2011). Further, the
anti-nociceptive effects of OXAwere endocannabinoid dependent
in the vlPAG (Ho et al., 2011) and endoncannabinoid inde-
pendent in the DH (Bingham et al., 2001). Moreover, orexin
mediates the analgesia in the model of stress-induced analge-
sia (Xie et al., 2008; Gerashchenko et al., 2011). Surprisingly, in
some instances anti-nociceptive effects of peripheral OXA injec-
tions have also been shown (Bingham et al., 2001; Holland et al.,
2005, 2006). Importantly, patients suffering from narcolepsy with
cataplexy, a condition associated with a disrupted OX/HCRT sys-
tem, experience a higher frequency of pain (Dauvilliers et al.,
2011). Anatomical and cellular studies may account for those
peripheral effects as OR1 and OXA have indeed been found in
DRG (Bingham et al., 2001) andOXA directlymodulates the DRG
neuronal activity (Yan et al., 2008).
Our data also allow us to speculate on the mechanism under-
lying the possible analgesic effects of peripheral OXA injections.
Indeed, OXA might affect SP-positive DRG neurons by bind-
ing to OR1, thus changing the DRG-mediated nociceptive action
and/or chronically adapting the pain sensation threshold. Such
findings may have practical importance in the wake of current
hypnotic drug development aiming at blocking orexin receptors
using peripheral routes (Scammell and Winrow, 2011).
MATERIALS AND METHODS
ANIMALS
Adult (6-month-old) male Wistar rats (300–350 g) were pur-
chased from Harlan (Italy), and all experiments were performed
according to the national and international laws for labora-
tory animal welfare and experimentation (EEC council directive
86/609, 12 December 1987) under a license issued by the Local
Animal Ethics Committee. Rats were kept under a 12-h dark–light
cycle, at 23 ± 1◦C, with food and water ad libitum.
SURGERY
Rats were anesthetized with chloral hydrate at 500mg/kg and sub-
jected to a laminectomy. Axonal transport was measured in DRs
3 or 6 h after the application of crushes on the right side of the
animal (Raivich et al., 1991; Delcroix et al., 1997) (Nota bene:
because of the thin nature of the DR tissue, crush was favored over
ligature). Crushes were made with watchmaker’s forceps, with
compression for a period of 30 s and repeated twice as in our pre-
vious work (Delcroix et al., 1997, 2003). After the laminectomy,
the wound was closed with Michel clips and the animal was mon-
itored for recovery. Axonal transport was measured in the SN by
placement of 2 tight ligatures using surgical silk for 12 h at mid
thigh as described elsewhere (Raivich et al., 1991; Delcroix et al.,
1997). At the end of the procedure 5mm of DRs was harvested on
both sides of the crush, proximal and distal to the DRG. Five mil-
limeter of SN was harvested on the side of the ligature proximal
to DRG (see schematic Figure 3A).
HOMOGENIZATION ANDWESTERN BLOTTING
A similar volume of tissue samples from the DRs, SN, and lum-
bar 4 and lumbar 5 (L4 and L5) DRGs was homogenized as
described previously (Filliatreau et al., 1988; Delcroix et al., 2003)
using a polytron (Kinematica, Luzern, Switzerland) in 200μl
of protein extraction buffer [0.1mM PBS (pH 7.4), 1.0mM of
NaF, 1.0mM NaVO4, 2.0mM EDTA, 0.5% Triton X-100, 1.0mM
phenyl methylsulphonyl fluoride (PMSF), and 10μg/ml apro-
tinin]. Total protein content was determined using Bio-Rad pro-
tein assay (Bradford method). SDS-Page gels were then loaded
with the same amount of material proportionally to 5mm of col-
lected sample [10μg (∼20μl) of total proteins from DR, SN, and
DRG tissues]. The separated proteins were transferred to PVDF
(Millipore, Billerica, Massachusetts, USA) using a Biorad Mini
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Trans-blot (30V overnight, at 4◦C). The blots were incubated
with a 1:200 dilution of OR1 (Santa Cruz antibodies #SC-8073,
Santa Cruz, California, USA) goat polyclonal antibody or with
a 1:200 dilution of OXA (Phoenix peptide #H-003-30, Belmont,
California) rabbit polyclonal antibody (Santa Cruz antibodies,
Santa Cruz, California, USA). Blots were then incubated with
the secondary antibody (anti-rabbit HRP conjugate or anti-goat
HRP conjugate from Jackson Immunoresearch Europe, UK) at
1:2000 for 60min at room temperature. Detection was achieved
using a Bio-rad Versadoc image analyzer (Bio-rad, Hercules,
California, USA). Band signal quantification was achieved using
ImageJ (NIH, Bethesda). Monoclonal mouse anti-actin antibody
(Sigma Aldrich) was then used as a loading control for western
blot analysis of proteins from rat DRG, SN, and DR.
IMMUNOCYTOCHEMISTRY
Wistar rats (6 months old) were prepared for immunohisto-
chemical analysis using standard techniques. Anesthesia was
induced with chloral hydrate (700mg/kg); animals were perfused
through the ascending aorta with saline followed by 300ml of
4% paraformaldehyde in 0.1M phosphate buffer, pH 7.4. L4 and
L5 DRGs and the lumbar spinal cord were removed, postfixes
overnight at 4◦C in the same fixative and then cryoprotected in
30% sucrose overnight. DRGs and spinal cord were frozen and
sectioned with a thickness of 10μm. Sections were stained using
indirect immunofluorescence histochemistry with a rabbit poly-
clonal antibody directed against OXA (Phoenix peptide #H-003-
30, Belmont, California) diluted at 1:250, a rabbit polyclonal anti-
body against p75NTR (#1405-41-0 Promega, Madison, Wisconsin,
USA) diluted at 1:250, a mouse monoclonal antibody against
SP (abcam #14184-50, Cambridge, UK) diluted at 1:250, a goat
polyclonal antibody directed against OR1 at 1:250 (Santa Cruz
antibodies #SC-8073, Santa Cruz, California, USA). For detec-
tion of primary polyclonal antibodies, a donkey anti-rabbit or
a donkey anti-goat Cy3 or Cy2 conjugated secondary antiserum
(1:250; Jackson Immunoresearch, Cambridge, UK) was used; for
detection of monoclonal antibodies, a donkey anti-mouse Cy3
or Cy2 conjugate was used (Jackson Immunoresearch). Double
labeling of SP together with OR1 was achieved using standard
indirect immunofluorescence as described elsewhere (Merighi
and Carmignoto, 2002). After final washes in phosphate buffered
saline (PBS), sections were coverslipped in a PBS/glycerol solu-
tion (1:3) containing 2.5% 1,4 diazobicyclo (2,2,2) octane
(antifading agent; Sigma). Immunoreactivity was visualized on
a Nikon 90i epifluorescence microscope linked to a C1 confocal
system.
3D reconstructions as shown in Figure 1 were produced
using the software Osirix, a freeware used for tomography
(http://homepage.mac.com/rossetantoine/osirix/Index2.html).
Twenty optical sections were taken every 0.4μm and were then
reconstructed in 3D.
CELL QUANTIFICATION
Cell size and cell density was calculated with ImageJ (NIH,
Bethesda). Cell size and staining intensity were quantified when a
clear nuclei was visible in the image. To decide if a cell was p75NTR
or OR1 positive, the following criteria was applied: an average
background was obtained by quantifying the average intensity
of 5 fields that did not show any staining in the image. Then, if
the intensity measured for a given neuron was 3 fold above back-
ground, the cell was considered positive for p75NTR or OR1. For
OXA and for p75NTR we quantified from 4 rats 2 sections taken
from the middle of the DRG. Numerical data are expressed as
mean ± standard deviation.
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